Pulmonary Arterial Hypertension Market 2025 to 2034
Pulmonary Arterial Hypertension Market 2025 to 2034
Pulmonary Arterial Hypertension Market (By Drug Class: Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators; By Type: Branded, Generics; By Route of Administration: Oral, Intravenous/Subcutaneous, Inhalational; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 8.48 Bn
Forecast Year, 2034
USD 13.50 Bn
CAGR, 2025 - 2034
5.30%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global pulmonary arterial hypertension market, valued at over USD 8.48 billion in 2025, is projected to reach approximately USD 13.50 billion by 2034, growing at a CAGR of 5.3%, driven by rising disease prevalence and therapeutic advancements.
Pulmonary Arterial Hypertension Market Size Analysis
Pulmonary Arterial Hypertension Market Size By Drug Class 2025 to 2034 (USD Billion)
| Drug Class | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Endothelin Receptor Antagonists (ERAs) | 0.86 | 0.90 | 0.94 | 1.00 | 1.06 | 1.11 | 1.17 | 1.22 | 1.28 | 1.36 |
| PDE-5 Inhibitors | 1.70 | 1.79 | 1.89 | 1.98 | 2.10 | 2.19 | 2.32 | 2.44 | 2.57 | 2.70 |
| Prostacyclin and Prostacyclin Analogs | 2.55 | 2.67 | 2.81 | 2.97 | 3.12 | 3.29 | 3.46 | 3.66 | 3.85 | 4.05 |
| SGC Stimulators | 3.38 | 3.56 | 3.76 | 3.95 | 4.16 | 4.38 | 4.61 | 4.86 | 5.12 | 5.39 |
Pulmonary Arterial Hypertension Market Size By Type 2025 to 2034 (USD Billion)
| Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Branded | 2.83 | 3.00 | 3.13 | 3.29 | 3.51 | 3.68 | 3.89 | 4.09 | 4.29 | 4.53 |
| Generics | 5.65 | 5.93 | 6.27 | 6.61 | 6.91 | 7.29 | 7.67 | 8.09 | 8.53 | 8.96 |
Pulmonary Arterial Hypertension Market Size By Route of Administration 2025 to 2034 (USD Billion)
| Route of Administration | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 1.42 | 1.49 | 1.59 | 1.65 | 1.73 | 1.83 | 1.94 | 2.03 | 2.14 | 2.28 |
| Intravenous/ subcutaneous | 2.83 | 2.97 | 3.14 | 3.30 | 3.48 | 3.66 | 3.86 | 4.06 | 4.26 | 4.48 |
| Inhalational | 4.22 | 4.46 | 4.68 | 4.95 | 5.21 | 5.49 | 5.75 | 6.08 | 6.41 | 6.74 |
Pulmonary Arterial Hypertension Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.86 | 0.91 | 0.94 | 1.00 | 1.05 | 1.11 | 1.16 | 1.23 | 1.30 | 1.36 |
| LAMEA | 1.69 | 1.78 | 1.88 | 1.98 | 2.08 | 2.20 | 2.31 | 2.43 | 2.56 | 2.71 |
| Europe | 2.54 | 2.67 | 2.82 | 2.96 | 3.12 | 3.29 | 3.47 | 3.65 | 3.85 | 4.05 |
| Asia-Pacific | 3.39 | 3.57 | 3.76 | 3.96 | 4.17 | 4.38 | 4.61 | 4.85 | 5.11 | 5.38 |
Pulmonary Arterial Hypertension Market Size to Hit USD 13.50 Billion by 2034
The global pulmonary arterial hypertension market size surpassed USD 8.48 billion in 2025 and is predicted to reach around USD 13.50 billion by 2034 with a registering a CAGR of 5.30%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
